The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Inflammatory Bowel Disease Treatment

IBD treatment — individualized therapy for flare-up control and long-term remission in Crohn's disease and ulcerative colitis.

A multi-step treatment approach that controls inflammatory flares, sustains remission, and reduces complications in Crohn's disease and ulcerative colitis.

Indication

  • Patients diagnosed with ulcerative colitis (continuous inflammation of the inner lining of the large intestine)
  • Patients diagnosed with Crohn's disease (deep inflammation in any segment of the digestive tract)
  • Recurrent diarrhea, abdominal pain, and bloody stools
  • Unexplained weight loss, fatigue, and growth retardation (in children)
  • Joint, skin, eye, or liver involvement accompanying IBD
  • Flares unresponsive or dependent on prior treatment
  • Maintenance of remission after surgery

Preparation

  • Colonoscopy, biopsy, imaging (CT/MR enterography), and laboratory tests are performed for diagnosis
  • The type, extent, and severity of the disease are evaluated (Crohn's vs ulcerative colitis differentiation)
  • Active infections (e.g., tuberculosis, hepatitis) are screened; required before biologic therapy
  • Vaccination status (especially hepatitis B, pneumococcus, influenza) is updated
  • Nutritional status, iron, and B12 deficiencies are evaluated

How it's performed

  1. In mild-moderate disease, 5-aminosalicylates (mesalamine) and topical therapies are used
  2. Corticosteroids are given for short periods during flares
  3. Immunomodulators (azathioprine, methotrexate) may be preferred to maintain remission
  4. In moderate-severe cases, biologic agents (anti-TNF, vedolizumab, ustekinumab) or small-molecule therapies are evaluated
  5. Nutritional support and iron/B12 replacement therapy are provided
  6. In complicated cases (stricture, fistula, refractory colitis), surgical consultation is planned

Post-procedure

  • Treatment response is monitored through clinical findings, blood tests, and stool calprotectin
  • Colonoscopic follow-ups may be recommended every 1-2 years depending on disease extent
  • Colon cancer screening is performed regularly in long-standing ulcerative colitis or extensive Crohn's disease
  • Nutrition, bone health, mental health, and vaccination are reviewed regularly
  • In female patients, pregnancy planning may affect treatment selection; multidisciplinary follow-up is recommended

Risks

  • Weight gain, bone loss, and elevated blood sugar related to corticosteroids
  • Risk of infection with immunomodulator and biologic therapy
  • Rare allergic reactions and skin rashes with some biologic agents
  • Risk of bowel stricture, fistula, or cancer related to long-standing inflammation
  • Possible loss of treatment response over time and need for medication change

FAQ

Can IBD be completely cured?

IBD is a chronic disease; current treatments do not eliminate it entirely, but long-term remission (quiet periods) can be achieved.

Are Crohn's and ulcerative colitis the same?

No. Ulcerative colitis affects only the inner lining of the large intestine, whereas Crohn's disease can affect any segment of the digestive tract throughout the full thickness of the wall.

Is nutritional therapy alone sufficient?

Nutritional support is an important complement, but in most patients it is not sufficient alone. It must be combined with appropriate medical therapy.

How will surgery affect my life if needed?

Surgery can significantly improve quality of life in selected cases. With modern techniques and follow-up, most patients continue their normal lives.